"Bidi" control with homotype antibody reagent
Taiwan·Risk Class 2·BD BIOSCIENCES IMMUNOCYTOMETRY SYSTEMS, A UNIT OF BECTON, DICKINSON AND COMPANY·Registered Apr 19, 2006 – Apr 19, 2011Cancelled- Analysis ID
- 0811f21337b041e1848087061a76cbc1
- Customs Code
- DHA00601643100
- Manufacturer Country
- United States
- Authorized Representative
- Taiwan Branch of American Business Bidi Co., Ltd
- Intended Use
- Fluorescence immunodetection was used to detect mouse immunoglobulin, which binds non-specifically to human cells, and was used as a control agent.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.4020 Analysis of specific tests
- Import Information
- import
- Registration Date
- Apr 19, 2006
- Expiry Date
- Apr 19, 2011
- Cancellation Date
- Oct 26, 2012
- Status
- Logged out
- Reason
- 許可證已逾有效期
Access comprehensive regulatory information for "Bidi" control with homotype antibody reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 0811f21337b041e1848087061a76cbc1 and manufactured by BD BIOSCIENCES IMMUNOCYTOMETRY SYSTEMS, A UNIT OF BECTON, DICKINSON AND COMPANY. The authorized representative in Taiwan is Taiwan Branch of American Business Bidi Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.